Literature DB >> 10650160

Effects of RO 60 0175, a 5-HT(2C) receptor agonist, in three animal models of anxiety.

G Kennett1, S Lightowler, B Trail, F Bright, S Bromidge.   

Abstract

There is some controversy as to whether 5-HT(2C) receptor agonists are anxiogenic or anxiolytic. The effects of the novel 5-HT(2C) receptor agonist, (S)-2-chloro-5-fluoro-indol-1-yl)-1-methyl ethylamine fumarate (RO 60 0175), in three models of anxiety were therefore tested. RO 60 0175 was found to induce hypolocomotion in rats at doses greater than 0.5 mg/kg s.c., an effect reversed by the selective 5-HT(2C) receptor antagonist, SB-242084. RO 60 0175 did not elicit anxiolytic-like responses in the social interaction test under high light unfamiliar conditions, but suppressed both time spent in social interaction and locomotion at doses of 1 and 3 mg/kg s.c., suggesting a sedative response. In the Vogel conflict test, RO 60 0175 had no significant action on the number of shocks taken. In the Geller-Seifter test, RO 60 0175 (0.3 and 1 mg/kg s.c.) simultaneously reduced both unpunished and punished lever pressing, a profile consistent with sedation. Finally, RO 60 0175 was tested in a rat social interaction test under low light familiar conditions optimal for the detection of anxiogenic-like responses. At 1 and 3 mg/kg s.c., RO 60 0175 reduced both time spent in social interaction and concurrent locomotion, a profile more consistent with sedation than anxiogenesis. In conclusion, RO 60 0175 induced sedative-like responses via 5-HT(2C) receptor activation, but was neither anxiolytic, nor clearly anxiogenic at the doses tested.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10650160     DOI: 10.1016/s0014-2999(99)00706-2

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  12 in total

1.  Agonist diversity in 5-HT(2C) receptor-mediated weight control in rats.

Authors:  Aska Hayashi; Masanori Suzuki; Masao Sasamata; Keiji Miyata
Journal:  Psychopharmacology (Berl)       Date:  2004-10-21       Impact factor: 4.530

Review 2.  A short history of the 5-HT2C receptor: from the choroid plexus to depression, obesity and addiction treatment.

Authors:  Jose M Palacios; Angel Pazos; Daniel Hoyer
Journal:  Psychopharmacology (Berl)       Date:  2017-03-07       Impact factor: 4.530

3.  On the behavioural specificity of hypophagia induced in male rats by mCPP, naltrexone, and their combination.

Authors:  F L Wright; R J Rodgers
Journal:  Psychopharmacology (Berl)       Date:  2013-10-11       Impact factor: 4.530

4.  A 5-HT1A agonist and a 5-HT2c antagonist reduce social interaction deficit induced by multiple ethanol withdrawals in rats.

Authors:  David H Overstreet; Darin J Knapp; Sheryl S Moy; George R Breese
Journal:  Psychopharmacology (Berl)       Date:  2003-04-04       Impact factor: 4.530

5.  Effect of genetic and pharmacological blockade of GABA receptors on the 5-HT2C receptor function during stress.

Authors:  Cédric B P Martin; Martin Gassmann; Caroline Chevarin; Michel Hamon; Uwe Rudolph; Bernhard Bettler; Laurence Lanfumey; Raymond Mongeau
Journal:  J Neurochem       Date:  2014-09-04       Impact factor: 5.372

6.  Influence of the 5-HT(2C) receptor antagonist SB242,084 on behaviour produced by the 5-HT(2) agonist Ro60-0175 and the indirect 5-HT agonist dexfenfluramine.

Authors:  G A Higgins; A M Ouagazzal; A J Grottick
Journal:  Br J Pharmacol       Date:  2001-06       Impact factor: 8.739

7.  Serotonin inhibition of the NMDA receptor/nitric oxide/cyclic GMP pathway in human neocortex slices: involvement of 5-HT(2C) and 5-HT(1A) receptors.

Authors:  G Maura; M Marcoli; O Pepicelli; C Rosu; C Viola; M Raiteri
Journal:  Br J Pharmacol       Date:  2000-08       Impact factor: 8.739

8.  Evidence for a role of 5-HT2C receptors in the motor aspects of performance, but not the efficacy of food reinforcers, in a progressive ratio schedule.

Authors:  G Bezzina; S Body; T H C Cheung; C L Hampson; C M Bradshaw; J C Glennon; E Szabadi
Journal:  Psychopharmacology (Berl)       Date:  2014-08-19       Impact factor: 4.530

9.  Pharmacological Modulation of 5-HT2C Receptor Activity Produces Bidirectional Changes in Locomotor Activity, Responding for a Conditioned Reinforcer, and Mesolimbic DA Release in C57BL/6 Mice.

Authors:  Caleb J Browne; Xiaodong Ji; Guy A Higgins; Paul J Fletcher; Colin Harvey-Lewis
Journal:  Neuropsychopharmacology       Date:  2017-06-13       Impact factor: 7.853

10.  S32006, a novel 5-HT2C receptor antagonist displaying broad-based antidepressant and anxiolytic properties in rodent models.

Authors:  Anne Dekeyne; Clotilde Mannoury la Cour; Alain Gobert; Mauricette Brocco; Françoise Lejeune; Florence Serres; Trevor Sharp; Annie Daszuta; Amélie Soumier; Mariusz Papp; Jean-Michel Rivet; Gunnar Flik; Thomas I Cremers; Olivier Muller; Gilbert Lavielle; Mark J Millan
Journal:  Psychopharmacology (Berl)       Date:  2008-06-04       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.